Seiter Christopher 4
4 · Trevi Therapeutics, Inc. · Filed Feb 19, 2021
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (right to buy)
2021-02-17+80,000→ 80,000 totalExercise: $3.21Exp: 2031-02-16→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 17, 2021. The 80,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 17, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 17, 2025.